Standardized 7-year financial series for BridgeBio Pharma, Inc., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.
Quarterly coverage: 17 periods · latest quarter FY2025-Q3 · TTM revenue growth 60.1%.
The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.
| Fiscal year | Revenue | Adj. EBITDA | EBIT | Net result | Op. cash flow | Capex | Net debt | Status |
|---|---|---|---|---|---|---|---|---|
| FY2019 | 41M | — | -266M | — | -254M | -3M | -272M | missing accounts receivable · missing adjusted ebitda · missing basic eps · missing cost of revenue · missing diluted eps · missing diluted weighted average shares · missing gross profit · missing inventory · missing net result |
| FY2020 | 8M | — | -474M | — | -400M | -8M | -262M | missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing gross profit · missing inventory · missing net result |
| FY2021 | 70M | — | -577M | — | -498M | -13M | 37M | missing accounts receivable · missing adjusted ebitda · missing gross profit · missing inventory · missing net result |
| FY2022 | 78M | — | -512M | — | -419M | -5M | 54M | missing accounts receivable · missing adjusted ebitda · missing gross profit · missing inventory · missing net result |
| FY2023 | 9M | — | -607M | — | -528M | -1M | 71M | missing adjusted ebitda · missing gross profit · missing inventory · missing net result |
| FY2024 | 222M | — | -593M | — | -521M | -933K | -244M | missing adjusted ebitda · missing gross profit · missing interest expense · missing net result |
| FY2025 | 502M | — | -523M | — | -446M | -1M | 1B | missing adjusted ebitda · missing gross profit · missing interest expense · missing net result |
SEC EDGAR companyfacts · XBRL · consolidated_reported
missing_accounts_receivable · missing_adjusted_ebitda · missing_basic_eps · missing_cost_of_revenue · missing_diluted_eps · missing_diluted_weighted_average_shares · missing_gross_profit · missing_inventory · missing_net_result
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_accounts_receivable · missing_adjusted_ebitda · missing_cost_of_revenue · missing_gross_profit · missing_inventory · missing_net_result
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_accounts_receivable · missing_adjusted_ebitda · missing_gross_profit · missing_inventory · missing_net_result
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_accounts_receivable · missing_adjusted_ebitda · missing_gross_profit · missing_inventory · missing_net_result
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_gross_profit · missing_inventory · missing_net_result
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_gross_profit · missing_interest_expense · missing_net_result
SEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_gross_profit · missing_interest_expense · missing_net_result
Open official source filing